Liquid chromatographic determination of sulindac and metabolites in serum.
An improved liquid chromatographic procedure is described for the quantitative determination of sulindac, sulindac sulfone, and sulindac sulfide from serum. The procedure makes use of acetonitrile extraction of the compounds of interest from acidified serum samples. Under these conditions extraction efficiencies in the 85 percent range are obtained for each of the compounds. The liquid chromatographic separation of the compounds of interest and the internal standard (indomethacin) is accomplished in an isocratic elution procedure using a nitrile (CN) stationary phase. The HPLC separation procedure is completed in less than 10 minutes, giving excellent resolution and peak shape.
D001711:Biotransformation; D002851:Chromatography, High Pressure Liquid; D006801:Humans; D007192:Indenes / Q000097:blood*; D013467:Sulindac / Q000097:blood* / Q000378:metabolism
D007192:Indenes; D013467:Sulindac